Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$249K Buy
+952
New +$244K 0.1% 102
2025
Q4
– Sell
-1,612
Closed -$373K – 89
2025
Q3
$373K Buy
+1,612
New +$328K 0.15% 86
2025
Q2
– Sell
-1,034
Closed -$217K – 118
2025
Q1
$217K Buy
+1,034
New +$201K 0.16% 86

Other funds holding ABBV

Tableaux's ABBV Position: Q3 2026 in Review

Tableaux opened a new position in AbbVie (ABBV) in Q3 2026: 952 shares worth $249K. The stake represents 0.1% of the portfolio and ranks #102 among its holdings. This is a return to the name: Tableaux previously reported a position in ABBV as recently as Q3 2025.

Tableaux first reported a position in ABBV in Q1 2025 and has held it in 3 quarters since. The position peaked at $373K in Q3 2025. 4,246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Tableaux held 952 shares of AbbVie worth $249K as of Q3 2026.
  • AbbVie was a new Tableaux position in Q3 2026.
  • AbbVie made up 0.1% of Tableaux's portfolio in Q3 2026, its #102 holding.
  • Tableaux first reported a position in AbbVie in Q1 2025 and has held it in 3 quarters since.
  • Tableaux's AbbVie position peaked at $373K in Q3 2025.
  • 4,246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Tableaux's 13F filing for Q3 2026, filed 23 Oct 2026.